Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary breast cancer].

Pål Møller1, Lovise Maehle, Jaran Apold

  • 1pmoller@ulrik.uio.no Norsk gruppe for arvelig kreft Seksjon for genetisk veiledning Radiumhospitalet 0310 Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|November 22, 2005
PubMed
Summary

Norwegian guidelines for inherited breast cancer risk management align with European standards. Genetic testing and interventions like MRI and oophorectomy are recommended for high-risk women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence Rates of Melanoma and Lung Cancer Are Generally Low in the Lynch Syndromes and Vary Across <i>path_MMR</i> Variants: A Prospective Lynch Syndrome Database Report.

Cancers·2026
Same author

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

European urology·2026
Same author

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>.

Current oncology (Toronto, Ont.)·2025
Same author

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Journal of the National Cancer Institute·2025
Same author

A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2.

BJC reports·2025

Area of Science:

  • Oncology
  • Genetics
  • Public Health

Context:

  • Norwegian healthcare guidelines for inherited breast cancer risk management.
  • Adherence to European consensus guidelines (1999) and Norwegian legislation on genetic testing.
  • Consensus document from the Norwegian Group on Inherited Cancer.

Purpose:

  • Update guidelines based on new knowledge, healthcare structure, and available resources.
  • Maintain indications for genetic testing referrals.
  • Standardize management for inherited breast and ovarian cancer.

Summary:

  • High-capacity testing for founder BRCA1 mutations is established.
  • Annual breast MRI is recommended for mutation carriers.
  • Prophylactic oophorectomy is advocated for BRCA mutation carriers and related kindreds.

Impact:

  • Ensures consistent and evidence-based care for women at risk of hereditary breast cancer.
  • Empowers clinical geneticists to coordinate patient services.
  • Facilitates collaborative research on intervention effectiveness.

Related Experiment Videos